Blog

Hantavirus: a primer

07/05/2026

A practical primer on hantavirus for healthcare professionals, covering transmission, incubation, case fatality rates, and IPC implications, with insights from recent outbreaks and NEJM evidence.

Tension between IPC risk and sustainability gain: looking for the win‑wins

06/05/2026

Exploring the tension between infection prevention and sustainability—and where real win‑wins exist, from PPE optimisation to antimicrobial stewardship.

Sink splash zone 2.0

05/05/2026

New evidence shows hospital sink splash zones can disperse Gram‑negative bacteria and carbapenem resistance, highlighting hidden water risks for IPC.

Rethinking single use: why safe reuse matters more than ever

30/04/2026

Why safe reuse in healthcare matters now: evidence shows reuse can deliver infection safety, lower carbon and more resilient supply chains.

Biofilms, drains, and the hidden risks in healthcare environments: disinfection strategies

29/04/2026

Why healthcare drains and biofilms matter for HCAI risk. Evidence, audience insights from IPC 2026, and practical challenges in drain disinfection strategies.

Travel‑associated carbapenem‑resistant organisms at a time of increasing geopolitical instability

16/04/2026

A review of new UK data on travel‑associated carbapenemase‑producing organisms (CPOs) during rising geopolitical instability, highlighting screening variation, key epidemiological trends, and implications for infection prevention and control.

Addressing healthcare inequalities in IPC

13/04/2026

Health inequalities drive infectious disease risk and HCAIs. Why equity matters for IPC, and how data‑led approaches can protect those at greatest risk.

Neisseria meningitidis: colonisation (the norm); infection (the exception)

25/03/2026

A clear, evidence‑based explainer on Neisseria meningitidis highlighting why asymptomatic colonisation is the norm, invasive meningococcal disease is the exception, and how this distinction shapes risk communication, IPC practice, and public‑health response.

Invasive meningococcal disease: a primer for IPC, clinical, and laboratory teams

16/03/2026

A technical primer on invasive meningococcal disease, published amid the Kent outbreak, covering pathogenesis, epidemiology, diagnosis, and IPC action.

Hospital‑onset bacteraemia as a surveillance outcome

09/03/2026

What proportion of hospital‑onset bloodstream infections are preventable? Insights for IPC teams from a major BMJ Quality & Safety multicentre study